Study Stopped
Evidence of bad outcome after interims analysis
Closure of Protective Ileostomy 2 vs. 12 Weeks After TME
Closure2vs12
1 other identifier
interventional
71
1 country
1
Brief Summary
The purpose of this study is to compare the feasibility, safety, and quality of life (QOL) in patients (pts) undergoing protective ileostomy closure after 2 weeks with a closure after 12 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 24, 2015
CompletedFirst Posted
Study publicly available on registry
November 20, 2015
CompletedAugust 31, 2017
January 1, 2017
6.3 years
September 24, 2015
August 29, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality Of Life (GQLI - Questionnaire)
Quality Of Life Survey using the GQLI - Questionnaire
6 weeks
Secondary Outcomes (4)
Feasibility (via Visual Analogue Scale)
intraoperatively
Safety as assessed by Morbidity, Mortality
6 weeks, 16 weeks
Quality Of Life (EORTC - Questionnaire)
preoperative (preOP), 6 weeks, 16 weeks
Quality Of Life (GQLI - Questionnaire)
preOP, 16 weeks
Study Arms (2)
2 weeks
EXPERIMENTALIleostomy closure after 2 weeks
12 weeks
EXPERIMENTALIleostomy closure after 12 weeks
Interventions
Eligibility Criteria
You may qualify if:
- anastomosis ≤ 5cm from anal verge
- age \>18 years
- informed consent
- uneventful course after first operation
You may not qualify if:
- pregnancy
- allergy to contrast agent
- severe non-surgical complications
- evident abdominal - pelvic complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kantonspital Baselland Liestal
Liestal, Basel-Landschaft, 4410, Switzerland
Related Publications (4)
Thalheimer A, Bueter M, Kortuem M, Thiede A, Meyer D. Morbidity of temporary loop ileostomy in patients with colorectal cancer. Dis Colon Rectum. 2006 Jul;49(7):1011-7. doi: 10.1007/s10350-006-0541-2.
PMID: 16598401BACKGROUNDO'Leary DP, Fide CJ, Foy C, Lucarotti ME. Quality of life after low anterior resection with total mesorectal excision and temporary loop ileostomy for rectal carcinoma. Br J Surg. 2001 Sep;88(9):1216-20. doi: 10.1046/j.0007-1323.2001.01862.x.
PMID: 11531870BACKGROUNDHallbook O, Matthiessen P, Leinskold T, Nystrom PO, Sjodahl R. Safety of the temporary loop ileostomy. Colorectal Dis. 2002 Sep;4(5):361-364. doi: 10.1046/j.1463-1318.2002.00398.x.
PMID: 12780582BACKGROUNDElsner AT, Brosi P, Walensi M, Uhlmann M, Egger B, Glaser C, Maurer CA. Closure of Temporary Ileostomy 2 Versus 12 Weeks After Rectal Resection for Cancer: A Word of Caution From a Prospective, Randomized Controlled Multicenter Trial. Dis Colon Rectum. 2021 Nov 1;64(11):1398-1406. doi: 10.1097/DCR.0000000000002182.
PMID: 34343161DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christoph A. Maurer, Prof.Dr.med.
Cantonal Hosptal, Baselland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2015
First Posted
November 20, 2015
Study Start
November 1, 2007
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
August 31, 2017
Record last verified: 2017-01